ISGlobal Awarded ISO 9001:2015 Certification for Its Immune Response and Biomarker Platform

The Immune Response and Biomarker Platform at the Barcelona Institute for Global Health (ISGlobal) has been awarded the ISO 9001:2015 certification, an internationally recognised standard confirming the implementation of effective quality management systems. The certification was granted by ICDQ, an independent body specialising in evaluating and certifying management systems.

This achievement was possible thanks to the Daniel Bravo Andreu Private Foundation, whose support was essential for developing and consolidating the platform. The certification covers the design and analysis of immune responses and biomarkers, including both the technical processes carried out in the laboratory and the strategic and support processes undertaken by the relevant administrative units.

ISO 9001:2015 is one of the world’s most widely recognised quality standards. It sets out strict criteria to ensure continuous improvement and a focus on user satisfaction. Key principles certified by this standard include:

• Customer focus: prioritising the needs of users and partners in everyday work.
• Process-based management: applying standardised and efficient procedures to ensure traceability and quality.
• Active team engagement: fostering an organisational culture in which staff participate proactively.
• Continuous improvement and innovation: ensuring services evolve and are constantly optimised.

This recognition not only validates ISGlobal’s commitment to quality and operational excellence, but also strengthens its position as a leading institution in the field of biomedical research and global health. The certification confirms that the services offered by the Immune Response and Biomarker Platform are delivered according to the highest international standards.